Steven C. Anaya Sells 5,500 Shares of Cantel Medical Corp. (CMN) Stock
Cantel Medical Corp. (NYSE:CMN) CAO Steven C. Anaya sold 5,500 shares of the company’s stock in a transaction on Monday, October 10th. The stock was sold at an average price of $77.07, for a total value of $423,885.00. Following the sale, the chief accounting officer now owns 48,132 shares of the company’s stock, valued at $3,709,533.24. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink.
Cantel Medical Corp. (NYSE:CMN) opened at 75.38 on Friday. The firm has a 50-day moving average price of $77.74 and a 200 day moving average price of $71.21. Cantel Medical Corp. has a 52-week low of $54.93 and a 52-week high of $81.63. The company has a market capitalization of $3.12 billion, a P/E ratio of 52.42 and a beta of 1.59.
Cantel Medical Corp. (NYSE:CMN) last announced its quarterly earnings results on Thursday, September 29th. The company reported $0.48 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.37 by $0.11. The company earned $179 million during the quarter. Cantel Medical Corp. had a return on equity of 16.70% and a net margin of 9.02%. Cantel Medical Corp.’s revenue for the quarter was up 18.3% compared to the same quarter last year. During the same quarter last year, the firm posted $0.39 earnings per share. On average, analysts predict that Cantel Medical Corp. will post $1.98 earnings per share for the current fiscal year.
Several equities analysts have commented on the company. Benchmark Co. set a $83.00 target price on Cantel Medical Corp. and gave the company a “buy” rating in a research report on Saturday, October 1st. Needham & Company LLC assumed coverage on Cantel Medical Corp. in a research report on Wednesday, August 24th. They issued a “hold” rating for the company.
Institutional investors have recently made changes to their positions in the stock. Acrospire Investment Management LLC boosted its position in shares of Cantel Medical Corp. by 51.2% in the second quarter. Acrospire Investment Management LLC now owns 1,477 shares of the company’s stock valued at $102,000 after buying an additional 500 shares during the period. LS Investment Advisors LLC boosted its position in shares of Cantel Medical Corp. by 7.5% in the second quarter. LS Investment Advisors LLC now owns 1,510 shares of the company’s stock valued at $104,000 after buying an additional 106 shares during the period. BlackRock Inc. boosted its position in shares of Cantel Medical Corp. by 119.5% in the first quarter. BlackRock Inc. now owns 2,355 shares of the company’s stock valued at $168,000 after buying an additional 1,282 shares during the period. Bank of Montreal Can bought a new position in shares of Cantel Medical Corp. during the second quarter valued at $203,000. Finally, Cypress Wealth Advisors LLC bought a new position in shares of Cantel Medical Corp. during the first quarter valued at $210,000. Institutional investors own 81.60% of the company’s stock.
Cantel Medical Corp. Company Profile
Cantel Medical Corp. is a provider of infection prevention and control products and services in the healthcare market. The Company’s segments include Endoscopy, Water Purification and Filtration, Healthcare Disposables, Dialysis and Specialty Packaging. Its Endoscopy segment includes medical device reprocessing systems, disinfectants, detergents and other supplies.
Receive News & Ratings for Cantel Medical Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cantel Medical Corp. and related companies with MarketBeat.com's FREE daily email newsletter.